Submitted March 18, 2005
Accepted September 25, 2006
The role of TLR2 in the inflammatory activation of mouse
fibroblasts by human antiphospholipid antibodies
Nathalie Satta, Sylvie Dunoyer-Geindre, Guido Reber, Richard J Fish, Francoise Boehlen, Egbert KO Kruithof, and Philippe de Moerloose*
Division of Angiology & Hemostasis, University Hospital, Faculty of Medicine, Geneva, Switzerland
* Corresponding author; email: philippe.demoerloose{at}hcuge.ch.
Antiphospholipid antibodies (APLA) promote inflammatory and procoagulant responses in endothelial cells and monocytes. Previous studies have shown that MyD88, TRAF6 and NF-
B mediate cell activation by APLA. These intermediates are also employed by Toll-like receptors (TLR). We investigated the role of TLRs in the cellular response to APLA. IgG were isolated from the plasma of five antiphospholipid syndrome patients and immunopurified anti-
2-glycoprotein 1 IgG from a sixth patient. Control IgG was obtained from a pool of healthy donor plasmas negative for APLA. Wild-type mouse embryonic fibroblasts (EF) and EF deficient in TLR1, TLR2, TLR4 or TLR6 were incubated with APLA, anti-
2-glycoprotein 1 IgG or control IgG. Upon incubation with the patient IgG, but not control IgG, a significant increase in mRNA levels of the inflammatory marker proteins MCP-1, ICAM-1 and IL-6 as well as IL-6 secretion was observed in wild-type EF, whereas TLR2-deficient EF did not respond. Responses in TLR1- and TLR6-deficient EF were decreased and those in TLR4-deficient EF comparable to those in wild-type EF. Overexpression of human TLR2 in the TLR2-deficient EF restituted the response to patient IgG. Our results imply that TLR2 plays a role in mouse fibroblast activation by APLA.